<code id='6F91F1411C'></code><style id='6F91F1411C'></style>
    • <acronym id='6F91F1411C'></acronym>
      <center id='6F91F1411C'><center id='6F91F1411C'><tfoot id='6F91F1411C'></tfoot></center><abbr id='6F91F1411C'><dir id='6F91F1411C'><tfoot id='6F91F1411C'></tfoot><noframes id='6F91F1411C'>

    • <optgroup id='6F91F1411C'><strike id='6F91F1411C'><sup id='6F91F1411C'></sup></strike><code id='6F91F1411C'></code></optgroup>
        1. <b id='6F91F1411C'><label id='6F91F1411C'><select id='6F91F1411C'><dt id='6F91F1411C'><span id='6F91F1411C'></span></dt></select></label></b><u id='6F91F1411C'></u>
          <i id='6F91F1411C'><strike id='6F91F1411C'><tt id='6F91F1411C'><pre id='6F91F1411C'></pre></tt></strike></i>

          leisure time

          leisure time

          author:entertainment    Page View:363
          Terry Horgan pictured at home -- coverage from STAT
          Terry Horgan in his family's Montour Falls, N.Y., home, in an undated photo. Kate Collins/The Journal via AP

          Last October, a 27-year-old man with Duchenne muscular dystrophy died after receiving a CRISPR-based treatment custom built to treat his particular genetic mutation.

          Results of a detailed investigation released on Wednesday suggest that the patient, Terry Horgan, likely died of a previously undocumented adverse effect of the virus used to deliver the CRISPR machinery to his cells.

          advertisement

          These viruses, known as adeno-associated viruses, or AAVs, are used in several approved drugs and hundreds of clinical trials to deliver genes into patients, because they are generally benign. But at high doses they can cause side effects and, occasionally, deaths through one of several mechanisms, such as directly injuring the liver or triggering a type of immune response known as complement activation.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          Crowdfunding for medical bills sidesteps core problem, author says
          Crowdfunding for medical bills sidesteps core problem, author says

          AdobeIntheUnitedStates,healthcarecostsaresooutofcontrolthatmedicalcrowdfundinghasbecomecommonplace.T

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          How medical schools plan to diversify without affirmative action

          Fromlefttoright,toprow:STAT'sUshaLeeMcFarling;Vanderbilt'sConsueloWilkins;CarolinaReyesofUCDavisHeal